ID

18932

Descripción

A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00072670

Link

https://clinicaltrials.gov/show/NCT00072670

Palabras clave

Versiones (1)
  1. 24/11/16 24/11/16 -
Subido en

24 de noviembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00072670

Inglés

Eligibility Prostate Cancer NCT00072670

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed adenocarcinoma of the prostate
Descripción

Adenocarcinoma of prostate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007112
radiographically documented metastatic disease
Descripción

Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027627
surgical or chemical castration
Descripción

Male Castration | Chemical male castration

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007347
UMLS CUI [2]
C0455189
prostate-specific antigen greater than or equal to (>=) 5 nanogram per milliliter (ng/ml)
Descripción

Prostate specific antigen measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201544
eastern cooperative oncology group performance status of 0, 1, or 2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
androgen independent disease
Descripción

androgen independent prostate cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1654637
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with chemotherapy or radiation therapy that was terminated at least 4 weeks before study entry
Descripción

Chemotherapy Discontinued | Therapeutic radiology procedure Discontinued

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C1444662
treatment with extensive external beam radiation therapy or radionuclide therapy within 6 weeks of study entry (palliative radiation involving less than 20 percent of bone marrow reserves must have been completed at least 4 weeks before study entry)
Descripción

External Beam Radiation Therapy Extensive | Radionuclide therapy Extensive | Palliative Radiation Therapy Complete | Palliative Radiation Therapy Involving Bone Marrow Mature Neutrophils Percentage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1517033
UMLS CUI [1,2]
C0205231
UMLS CUI [2,1]
C0203608
UMLS CUI [2,2]
C0205231
UMLS CUI [3,1]
C3898008
UMLS CUI [3,2]
C0205197
UMLS CUI [4,1]
C3898008
UMLS CUI [4,2]
C1314939
UMLS CUI [4,3]
C0005953
UMLS CUI [4,4]
C1708947
UMLS CUI [4,5]
C0439165
participant not employing adequate contraception
Descripción

Contraceptive methods Adequate Lacking

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0205411
UMLS CUI [1,3]
C0332268
other serious illness or medical conditions as : uncontrolled congestive heart failure or history of myocardial infection or active angina pectoris within six months preceding registration; active infectious process; chronic active liver disease, including chronic hepatitis b, chronic hepatitis c, or cirrhosis
Descripción

Illness Serious | Medical condition | Congestive heart failure Uncontrolled | Myocardial Infarction | Angina Pectoris | INFECTIOUS PROCESS | Chronic liver disease | Hepatitis B, Chronic | Hepatitis C, Chronic | Liver Cirrhosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C3843040
UMLS CUI [3,1]
C0018802
UMLS CUI [3,2]
C0205318
UMLS CUI [4]
C0027051
UMLS CUI [5]
C0002962
UMLS CUI [6]
C0745283
UMLS CUI [7]
C0341439
UMLS CUI [8]
C0524909
UMLS CUI [9]
C0524910
UMLS CUI [10]
C0023890
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00072670

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
histologically confirmed adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Neoplasm Metastasis
Item
radiographically documented metastatic disease
boolean
C0027627 (UMLS CUI [1])
Male Castration | Chemical male castration
Item
surgical or chemical castration
boolean
C0007347 (UMLS CUI [1])
C0455189 (UMLS CUI [2])
Prostate specific antigen measurement
Item
prostate-specific antigen greater than or equal to (>=) 5 nanogram per milliliter (ng/ml)
boolean
C0201544 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group performance status of 0, 1, or 2
boolean
C1520224 (UMLS CUI [1])
androgen independent prostate cancer
Item
androgen independent disease
boolean
C1654637 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Discontinued | Therapeutic radiology procedure Discontinued
Item
treatment with chemotherapy or radiation therapy that was terminated at least 4 weeks before study entry
boolean
C0392920 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
External Beam Radiation Therapy Extensive | Radionuclide therapy Extensive | Palliative Radiation Therapy Complete | Palliative Radiation Therapy Involving Bone Marrow Mature Neutrophils Percentage
Item
treatment with extensive external beam radiation therapy or radionuclide therapy within 6 weeks of study entry (palliative radiation involving less than 20 percent of bone marrow reserves must have been completed at least 4 weeks before study entry)
boolean
C1517033 (UMLS CUI [1,1])
C0205231 (UMLS CUI [1,2])
C0203608 (UMLS CUI [2,1])
C0205231 (UMLS CUI [2,2])
C3898008 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C3898008 (UMLS CUI [4,1])
C1314939 (UMLS CUI [4,2])
C0005953 (UMLS CUI [4,3])
C1708947 (UMLS CUI [4,4])
C0439165 (UMLS CUI [4,5])
Contraceptive methods Adequate Lacking
Item
participant not employing adequate contraception
boolean
C0700589 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
Illness Serious | Medical condition | Congestive heart failure Uncontrolled | Myocardial Infarction | Angina Pectoris | INFECTIOUS PROCESS | Chronic liver disease | Hepatitis B, Chronic | Hepatitis C, Chronic | Liver Cirrhosis
Item
other serious illness or medical conditions as : uncontrolled congestive heart failure or history of myocardial infection or active angina pectoris within six months preceding registration; active infectious process; chronic active liver disease, including chronic hepatitis b, chronic hepatitis c, or cirrhosis
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2])
C0018802 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
C0002962 (UMLS CUI [5])
C0745283 (UMLS CUI [6])
C0341439 (UMLS CUI [7])
C0524909 (UMLS CUI [8])
C0524910 (UMLS CUI [9])
C0023890 (UMLS CUI [10])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial